|Table of Contents|

Research progress on the relationship between Fusobacterium nucleatum and colorectal cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2021 04
Page:
712-715
Research Field:
Publishing date:

Info

Title:
Research progress on the relationship between Fusobacterium nucleatum and colorectal cancer
Author(s):
DING Bin; ZENG Huiming; LUO Liqiong
Department of Oncology,Tianyou Hospital Affiliated to Wuhan University of Science and Technology,Hubei Wuhan 434000,China.
Keywords:
colorectal cancer; Fusobacterium nucleatum; genesis and development; prognosis
PACS:
R735.3
DOI:
10.3969/j.issn.1672-4992.2021.04.039
Abstract:
Colorectal cancer is one of the most common malignant tumors in the world and in china.In the past ten years,the incidence and fatality rate of the disease have shown an obvious upward trend.Its occurrence is a multi-factor and multi-step process,such as heredity,environment,microorganism and so on.More and more studies have shown that Clostridium nucleosus (Fusobacterium nucleatum,Fn) plays an important role in the occurrence and development of colorectal cancer.To study how Clostridium nucleosus promotes the occurrence and development of colorectal cancer and how it affects the prognosis of patients with colorectal cancer is of great significance for our diagnosis and prevention and treatment of colorectal cancer.In this paper,the latest progress is reviewed.

References:

［1］FERLAY J,SOERJOMATARAM I,DIKSHITR,et al.Cancer incidence and mortality worldwide:Sources，methods and major patterns in globocan［J］.Int J Cancer,2015,136(5):359-386.
［2］CHUNCHUN WU,MENGNA LI,HANBING MENG,et al.Analysis of status and countermeasures of cancer incidence and mortality in China［J］.Science China(Life Sciences),2019,62(05):640-647.
［3］CHIU HM,HSU WF,CHANG LC,et al.Colorectal cancer screening in Asia［J］.Curr Gastroenterol Rep,2017,19(10):47-47.
［4］DASHTISG,BUCHANANDD,JAYASEKARA H,et al.Alcoholconsumption and the risk of colorectal cancer in mismatch repair genemutation carrie［J］.Cancer Epidemiol Biomarkers Prev,2017,26(3):366-375.
［5］BAKKENT,BRAATENT,OLSENA,et al.Milk and risk of colorectal,colon and rectal cancer in the Norwegian Women and Cancer( NOWAC) Cohort Study［J］.Br J Nutr,2018,119(11):1274-1285.
［6］HERBERT TILG,TIMON E ADOLPH,ROMANA R,et al.The intestinal microbiota in colorectal cancer［J］.Cancer Cell,2018,33(6):954-964.
［7］GHOLIZADEH P,ESLAMI H,KAFIL HS.Carcinogenesis mechanisms of Fusobacterium nucleatum ［J］.Biomed Pharmacother，2017,89:918-925.
［8］YU J,FENG Q,WONG SH,et al.Metagenomic analysis of faecal micro-Biomeas a tool toward stargeted non-invasive biomarkers for colorectal cancer ［J］.Gut,2017,66(1):70-78.
［9］AHN J,SINHA,PEI Z,et al.Human gut microbiome and risk forcolorectal cancer［J］.J Natl Cancer Inst,2013,105(24):1907-1911.
［10］王昆,贾银平,朱攀,等.具核梭杆菌诱导的肠上皮细胞-炎症反应及凋亡［J］.免疫学杂志,2015,31(4):313-317. WANG K,JIA YP,ZHU P,et al.Inflammatory response and apoptosis of intestinal epithelial cells induced by Clostridium nucleosus［J］.Journal of Immunology,2015,31(4):313-317.
［11］TAHARA T,YAMAMOTO E,SUZUKI H,et al.Fusobacterium in colonic flora and molecular features of colorectal carcinoma［J］.Cancer Res,2014,74(5):1311-1318.
［12］董艳玲,杨立娟,吴金鹏.结肠癌患者口腔具核梭杆菌与结肠癌发生关系的研究［J］.癌症进展,2016,14(4):387-389. DONG YL,YANG LJ,WU JP.Study on the relationship between Clostridium nucleosus in oral cavity and the occurrence of colon cancer in patients with colon cancer［J］.Cancer Progress,2016,14(4):387-389.
［13］KOSTIC AD,GEVERS D,PEDAMALLU CS,et al.Genomic analysis identifies association of Fusobacterium with colorectal carcinoma［J］.Genome Res,2012,22(2):292-298.
［14］MARCHESI JR,DUTILH BE,HALL N,et al.Towards the human colorectal cancer microbiome［J］.PLoS One,2011,6(5):204-247.
［15］TJALSMA H,BOLEIJ A,MARCHESI JR,et al.A bacterial driver-pas senger model for colorectal cancer:Beyond the usual suspects［J］.Nat Rev Microbiol,2012,10(8):575-582.
［16］NOUGAYREDE JP,OSWALD E.Microbiota and colorectal cancer:Genotoxic bacteria in the intestinal tract［J］.Bull Acad Natl Med,2011,195(6):1295-1304.
［17］ARTHUR JC,GHARAIBEH RZ,MUHIBAUER M,et al.Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer［J］.Nat Commun,2014,5(9):4724-4724.
［18］DEJEA CM,FATHI P,CRAIG JM,et al.Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria［J］.Science,2018,359(6375):592-597.
［19］郭伯敏.具核梭杆菌促进大肠癌发生的相关性研究［D］.上海:上海交通大学,2015. GUO BM.Study on the relationship between Clostridium nucleatum and Clostridium nucleatum in promoting the occurrence of colorectal cancer［D］.Shanghai:Shanghai Jiao Tong University,2015.
［20］王淙垲,刘汉嘉,黄永智,等.哮喘患儿外周血单核细胞中样受体表达及意义［J］.中华实用诊断与治疗杂志,2015,29(12):1212-1214. WANG ZK,LIU HJ,HUANG YZ,et al.Expression and significance of like receptors in peripheral blood monocytes of children with asthma［J］.Chinese Journal of Practical Diagnosis and Treatment,2015,29(12):1212-1214.
［21］陆诗媛,严婷婷,郭方方,等.白介素-与具核梭杆菌在结直肠癌发生发展中的协同作用［J］.中国科学,2018,048(006):684-691. LU SY,YAN TT,GUO FF,et al.Synergistic effect of IL-and clostridium nucleatum in the occurrence and development of colorectal cancer［J］.Chinese Science,2018,048(006):684-691.
［22］陈婷,邬亚鑫,李青,等.核梭杆菌内毒素上调-信号通路参与结直肠癌发生［J］.西南医科大学学报,2017,40(4):383-387. CHEN T,WU YX,LI Q,et al.Up-regulation of clostridium nucleosus endotoxin signal pathway involved in the occurrence of colorectal cancer［J］.Journal of Southwest Medical University,2017,40(4):383-387.
［23］STRAUSS J,KAPLAN GG,BECK PL,et al.Invasive potential of gutmucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host［J］.Inflamm Bowel Dis,2011,17(9):1971-1978.
［24］HAGLAND HR,SOREIDE K.Cellular metabolism in colorectal carcinogenesis:Influence of lifestyle,gut microbiome and metabolic pathways［J］.Cancer Letters,2015,356(2):273-280.
［25］殷薛飞,刘晓慧,申华莉,等.具核梭杆菌具核亚种蛋白质组及其在癌症环境下的差异蛋白质组分析［J］.化学学报,2015,73(4):337-342. YIN XF,LIU XH,SHEN HL,et al.Nuclear subspecies proteome of Clostridium nucleosus and its differential proteome analysis in cancer environment［J］.Journal of Chemistry,2015,73(4):337-342.
［26］GUR C,IBRAHIM Y,ISAACSON B,et al.Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack［J］.Immunity,2015,42(2):344-355.
［27］JEWETT A，HUME WR，LE H，et al.Induction ofapoptotic cell death in peripheral blood mononuclearand polymorphonuclear cells by an oral bacterium,Fusobacterium nucleatum［J］.Infect Inlnqun,2000,68(4):1893-1898.
［28］MIMA K,NISHIHARA R,QIAN ZR,et al.Fusobacterium nucleatumin colorectal carcinoma tissue and patient prognosis［J］.Gut,2016,65(12):1973-1980.
［29］VILJOEN KS，DAKSHINAMURTHYA，GOLDBERGP,et al.Quantitve profiling of colorectal cancer-associated bacteria revealsassociations between fusobactrium spp,enterotoxigenic bacteroides fragilis(ETBF) and clinic opathoIogical features of colorectal cancer［J］.Plos One,2015,10(3):119-462.
［30］ITO M,KANNO S,NOSHO K,et al.Association of fusobactrium nucleatum with clinical and molecular features in colorectal semted pathway［J］.Int J Cancer,2015,137(6):1258-1268.
［31］STRAUSS J，WHITE A,AMBMSE C,et al.Phenotypic and genotypicanalyses of clinical，fusobactrium nucleatum and fusobactrium nucleatum isolates from the human gut［J］.Anaerobe,2008,14(6):301-309.
［32］CASTELLARIN M,WALLEN RL,FREEMAN JD,et al.Fusobacterium nucleatumm infection is prevalent in human colorectal carcinoma［J］.Genome Res,2012,22(2):299-306.
［33］BULLMAN S,PEDAMALLU CS,SICINSKA E,et al.Analysis of Fusobacterium unpersistence and antibiotic response in colorectal cancer［J］.Science,2017,358(6369):1443-1448.
［34］YU T,GUO F,YU Y,et al.Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy［J］.Cell,2017,170(3):548-563.

Memo

Memo:
-
Last Update: 1900-01-01